Lista de obras -

18F-FDG PET/CT and nestin expression as prognostic tools in pulmonary neuroendocrine tumours

scientific article published on 01 April 2019

Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls

artículo científico publicado en 2016

Clinical features of gastroenteropancreatic tumours

artículo científico publicado en 2015

Clinical significance of nestin and its association with survival in neuroendocrine lung tumours

artículo científico publicado en 2017

Combined octreotide and peptide receptor radionuclide therapy ((90)Y-DOTA-TATE) in case of malignant insulinoma

artículo científico publicado el 1 de enero de 2012

Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas.

artículo científico publicado en 2012

Delayed diagnosis of primary hyperparathyroidism in a patient with osteoclastoma ⬇️

artículo científico publicado el 1 de septiembre de 2011

Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen

artículo científico publicado en 2017

Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases

artículo científico publicado en 2016

Effect of Peptide Receptor Radionuclide Therapy (PRRT) with tandem isotopes - [90Y]Y/[177Lu]Lu-DOTATATE in patients with disseminated neuroendocrine tumours depending on qualification [18F]FDG PET/CT in Polish multicenter experience - do we need [18

artículo científico publicado en 2020

Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6‑month follow‑up.

artículo científico publicado en 2016

Epithelioid angiomyolipoma mimicking adrenal cortical carcinoma: A diagnostic pitfall

artículo científico publicado en 2015

Familial syndromes associated with neuroendocrine tumours

artículo científico publicado en 2015

Fatal course of cyclic Cushing's disease - lessons from a case.

artículo científico publicado en 2011

Growth hormone-secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog (90)Y-DOTATATE: case report

artículo científico publicado en 2015

Hindgut neuroendocrine neoplasms - characteristics and prognosis

artículo científico publicado en 2017

Lack of TSH stimulation in patients with differentiated thyroid cancer - possible causes

artículo científico publicado el 6 de julio de 2012

Management of the hormonal syndrome of neuroendocrine tumors

artículo científico publicado en 2016

Pituitary Microsomal Autoantibodies in Patients with Childhood-Onset Combined Pituitary Hormone Deficiency: an Antigen Identification Attempt

artículo científico publicado en 2016

Polish Experience in Peptide Receptor Radionuclide Therapy

scientific article published on 01 January 2013

Purification of pituitary autoantigen by column liquid chromatography and chromatofocusing.

artículo científico publicado en 2014

Radioiodine therapy and Graves' disease - Myths and reality

scientific article published on 13 January 2020

Recurrent goiter: risk factors, patient quality of life, and efficacy of radioiodine therapy

artículo científico publicado en 2018

SEMA3A and IGSF10 Are Novel Contributors to Combined Pituitary Hormone Deficiency (CPHD)

artículo científico publicado en 2020

Serum Visfatin does not seem to be a Useful Marker to Guide Glucocorticoid Substitution in Adrenal Insufficiency

scientific article published on 06 April 2020

Struma ovarii maligna

artículo científico publicado en 2013

Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level

artículo científico publicado en 2017

Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

scientific article published on 24 January 2020

The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population

artículo científico publicado en 2015

Transferase S-glutathione class pi gene (GSTP1) polymorphism in thyroid cancer patients

artículo científico publicado en 2006

Vitamin D deficiency and thyroid autoantibody fluctuations in patients with Graves' disease - A mere coincidence or a real relationship?

scientific article published on 26 December 2019

[High level of hsCRP in patients with Graves' ophthalmopathy--preliminary study]

artículo científico publicado en 2004

[The incidence of the pituitary autoantibodies in Addison disease]

artículo científico publicado en 2008

[The incidence of the pituitary autoantibodies in Graves' disease]

artículo científico publicado en 2007

[The incidence of the thyroid microsomal autoantibodies in Alzheimer disease]

scientific article published on 01 July 2009

Lista de obras de

18F-FDG PET/CT and nestin expression as prognostic tools in pulmonary neuroendocrine tumours

Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls

Clinical features of gastroenteropancreatic tumours

Clinical significance of nestin and its association with survival in neuroendocrine lung tumours

Combined octreotide and peptide receptor radionuclide therapy ((90)Y-DOTA-TATE) in case of malignant insulinoma

Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas.

Delayed diagnosis of primary hyperparathyroidism in a patient with osteoclastoma ⬇️

Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen

Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases

Effect of Peptide Receptor Radionuclide Therapy (PRRT) with tandem isotopes - [90Y]Y/[177Lu]Lu-DOTATATE in patients with disseminated neuroendocrine tumours depending on qualification [18F]FDG PET/CT in Polish multicenter experience - do we need [18

Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6‑month follow‑up.

Epithelioid angiomyolipoma mimicking adrenal cortical carcinoma: A diagnostic pitfall

Familial syndromes associated with neuroendocrine tumours

Fatal course of cyclic Cushing's disease - lessons from a case.

Growth hormone-secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog (90)Y-DOTATATE: case report

Hindgut neuroendocrine neoplasms - characteristics and prognosis

Lack of TSH stimulation in patients with differentiated thyroid cancer - possible causes

Management of the hormonal syndrome of neuroendocrine tumors

Pituitary Microsomal Autoantibodies in Patients with Childhood-Onset Combined Pituitary Hormone Deficiency: an Antigen Identification Attempt

Polish Experience in Peptide Receptor Radionuclide Therapy

Purification of pituitary autoantigen by column liquid chromatography and chromatofocusing.

Radioiodine therapy and Graves' disease - Myths and reality

Recurrent goiter: risk factors, patient quality of life, and efficacy of radioiodine therapy

SEMA3A and IGSF10 Are Novel Contributors to Combined Pituitary Hormone Deficiency (CPHD)

Serum Visfatin does not seem to be a Useful Marker to Guide Glucocorticoid Substitution in Adrenal Insufficiency

Struma ovarii maligna

Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level

Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population

Transferase S-glutathione class pi gene (GSTP1) polymorphism in thyroid cancer patients

Vitamin D deficiency and thyroid autoantibody fluctuations in patients with Graves' disease - A mere coincidence or a real relationship?

[High level of hsCRP in patients with Graves' ophthalmopathy--preliminary study]

[The incidence of the pituitary autoantibodies in Addison disease]

[The incidence of the pituitary autoantibodies in Graves' disease]

[The incidence of the thyroid microsomal autoantibodies in Alzheimer disease]